Vitalhub Corp. (TSE:VHI - Get Free Report) has received a consensus rating of "Buy" from the seven ratings firms that are currently covering the stock, Marketbeat Ratings reports. Six research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price target among brokers that have issued ratings on the stock in the last year is C$13.86.
A number of research analysts recently issued reports on the stock. Scotiabank lowered their target price on shares of Vitalhub from C$15.00 to C$12.00 and set an "outperform" rating on the stock in a research note on Wednesday, February 4th. Royal Bank Of Canada decreased their price target on shares of Vitalhub from C$13.00 to C$12.00 and set an "outperform" rating on the stock in a research report on Monday, January 26th. Raymond James Financial decreased their price target on shares of Vitalhub from C$15.00 to C$11.00 and set an "outperform" rating on the stock in a research report on Tuesday, March 24th. Finally, ATB Cormark Capital Markets decreased their price target on shares of Vitalhub from C$16.50 to C$15.00 and set an "outperform" rating on the stock in a research report on Tuesday, March 10th.
Read Our Latest Research Report on Vitalhub
Vitalhub Trading Down 0.5%
TSE:VHI opened at C$7.99 on Wednesday. Vitalhub has a 1 year low of C$6.67 and a 1 year high of C$14.64. The firm's fifty day simple moving average is C$7.69 and its 200 day simple moving average is C$8.67. The firm has a market capitalization of C$505.22 million, a PE ratio of 79.90, a PEG ratio of 1.18 and a beta of 0.87.
Vitalhub (TSE:VHI - Get Free Report) last posted its earnings results on Wednesday, March 18th. The company reported C$0.06 earnings per share (EPS) for the quarter. Vitalhub had a net margin of 5.61% and a return on equity of 2.75%. The business had revenue of C$31.39 million for the quarter. As a group, analysts anticipate that Vitalhub will post 0.2296467 EPS for the current fiscal year.
Insider Buying and Selling at Vitalhub
In related news, Director Francis Nelson Shen purchased 50,000 shares of the firm's stock in a transaction on Thursday, March 26th. The shares were bought at an average cost of C$6.99 per share, for a total transaction of C$349,500.00. Following the transaction, the director directly owned 50,000 shares of the company's stock, valued at approximately C$349,500. This trade represents a ∞ increase in their position. Also, Director Anthony Pius Shen purchased 7,000 shares of the firm's stock in a transaction on Monday, March 30th. The stock was bought at an average price of C$7.11 per share, for a total transaction of C$49,770.00. Following the completion of the transaction, the director directly owned 12,470 shares in the company, valued at approximately C$88,661.70. The trade was a 127.97% increase in their ownership of the stock. Insiders acquired a total of 496,600 shares of company stock worth $3,476,470 over the last 90 days. Company insiders own 18.57% of the company's stock.
About Vitalhub
(
Get Free Report)
Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Vitalhub, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.
While Vitalhub currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.